Valuation Autolus Therapeutics plc

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-27 EDT			5-day change	1st Jan Change
1.460 ^USD	+0.69%		+4.29%	-26.63%

07-27	European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading	MT
07-24	European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	378.4	328.8	1,120	625.4	529.6	388.6	-	-
Change	-	-13.12%	240.67%	-44.17%	-15.31%	-26.63%	-	-
Enterprise Value (EV) ¹	68.11	-53.95	879.8	89.99	300.3	349	437	422.4
Change	-	-179.21%	1,730.86%	-89.77%	233.7%	16.23%	25.2%	-3.33%
P/E	-2.63x	-1.21x	-5.37x	-2.73x	-1.84x	-1.65x	-2.32x	-3.56x
PBR	1.51x	1.1x	10x	1.46x	2.97x	13.3x	-4.56x	-
PEG	-	0.1x	0.2x	0.1x	-0.1x	0.1x	0.1x	0.1x
Capitalization / Revenue	162x	51.7x	660x	61.8x	7.03x	3.02x	2.03x	1.31x
EV / Revenue	29.2x	-8.48x	518x	8.89x	3.98x	2.71x	2.29x	1.42x
EV / EBITDA	-0.44x	0.35x	-5.08x	-0.39x	-1.15x	-1.6x	-2.61x	-3.27x
EV / EBIT	-0.42x	0.33x	-4.9x	-0.37x	-1.11x	-1.55x	-2.59x	-3.44x
EV / FCF	-0.54x	0.44x	-5.62x	-0.39x	-0.99x	-2.02x	-3.56x	-5.13x
FCF Yield	-186%	228%	-17.8%	-254%	-101%	-49.6%	-28.1%	-19.5%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-1.97	-1.57	-1.2	-0.86	-1.08	-0.8872	-0.6304	-0.4096
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	2.33	6.36	1.698	10.12	75.39	128.6	191	296.6
EBITDA ¹	-154.2	-154.3	-173.1	-233.7	-260.7	-217.9	-167.4	-129.2
EBIT ¹	-162.7	-161.7	-179.7	-241.4	-270.5	-225.3	-168.6	-122.8
Net income ¹	-142.1	-148.8	-208.4	-220.7	-287.5	-242.4	-184.7	-139.8
Net Debt ¹	-310.3	-382.8	-240.3	-535.4	-229.3	-39.53	48.41	33.86
Reference price ²	5.190	1.900	6.440	2.350	1.990	1.460	1.460	1.460
Nbr of stocks (in thousands)	72,919	173,059	173,937	266,122	266,143	266,143	-	-
Announcement Date	3/10/22	3/7/23	3/14/24	3/20/25	3/27/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
AUTOLUS THERAPEUTICS PLC	-1.65x	2.71x	-1.6x	-	389M
REGENERON PHARMACEUTICALS, INC.	17.64x	3.78x	9.76x	0.58%	67.88B
UCB	26.33x	5.45x	16.01x	0.6%	53.23B
SAMSUNG BIOLOGICS CO.,LTD.	37.7x	12.83x	24.43x	-.--%	48.71B
CSL LIMITED	-43.2x	3.1x	9.18x	3.5%	38.98B
BIOGEN INC.	24.81x	3.46x	11.92x	-.--%	29.55B
INCYTE CORPORATION	67.61x	3.45x	25.63x	-.--%	23.75B
MODERNA, INC.	-6.42x	8.92x	-5.49x	-.--%	22.07B
BRIDGEBIO PHARMA, INC.	-37.81x	18.02x	-49.34x	-.--%	16.49B
SWEDISH ORPHAN BIOVITRUM AB	24.4x	5.22x	13.67x	-.--%	16.57B
Average	10.94x	6.70x	5.42x	0.52%	31.76B
Weighted average by Cap.	14.89x	6.48x	10.43x	0.65%